TrademarkDir
NEUEXCELL
DEAD

Serial Number

97087345

Owner

NeuExcell Therapeutics Inc.

Attorney

Lawrence M. Green

Filing Date

Oct 22, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEUEXCELL Trademark

Serial Number: 97087345

NEUEXCELL is a trademark filed by NeuExcell Therapeutics Inc. on October 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NeuExcell Therapeutics Inc. (4 trademarks)

Suite 242
Philadelphia, PA 19108

Entity Type: 03

Trademark Details

Filing Date

October 22, 2021

Registration Date

Not Registered

Published for Opposition

February 14, 2023

Goods & Services

Pharmaceuticals for treating Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis (ALS), Huntington's Disease, epilepsy, spinal cord injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, viral and baterial infections, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, and cerebral venous sinus thrombosis

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 18, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 18, 2026 ABN6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 18, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 18, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 24, 2025 EX5G
SOU EXTENSION 5 FILED
Aug 22, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 24, 2025 EXRA
SOU EXTENSION 4 GRANTED
Mar 23, 2025 EX4G
SOU EXTENSION 4 FILED
Mar 23, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 28, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 28, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 5, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 26, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 26, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 26, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 26, 2021 NWAP

Related Trademarks

More from this Owner

NEUEXCELL

NEUEXCELL

NEUEXCELL

NEUEXCELL

NEUEXCELL

NEUEXCELL

ATN ASTROCYTES TO NEURONS

ATN ASTROCYTES TO NEURONS

ATN

ATN

ATN ASTROCYTES TO NEURONS

ATN ASTROCYTES TO NEURONS